Olfactory loss in people with cystic fibrosis: Community perceptions and impact

IF 5.4 2区 医学 Q1 RESPIRATORY SYSTEM Journal of Cystic Fibrosis Pub Date : 2024-11-01 DOI:10.1016/j.jcf.2023.11.006
Jessa E. Miller , Christine M. Liu , Edith T. Zemanick , Jason C. Woods , Christopher H. Goss , Jennifer L. Taylor-Cousar , Daniel M. Beswick
{"title":"Olfactory loss in people with cystic fibrosis: Community perceptions and impact","authors":"Jessa E. Miller ,&nbsp;Christine M. Liu ,&nbsp;Edith T. Zemanick ,&nbsp;Jason C. Woods ,&nbsp;Christopher H. Goss ,&nbsp;Jennifer L. Taylor-Cousar ,&nbsp;Daniel M. Beswick","doi":"10.1016/j.jcf.2023.11.006","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Olfactory dysfunction (OD) is prevalent in people with cystic fibrosis (PwCF) and can negatively impact quality-of-life (QOL). This study evaluated perceptions of OD, investigated how OD impacts QOL, and assessed willingness to participate in OD research among the CF community.</div></div><div><h3>Methods</h3><div>A 21-question survey was distributed through the CF Foundation's Community Voice program in 2023. The survey included questions on olfaction and interest in research. The Brief Questionnaire of Olfactory Disorders (BQOD), a validated person-reported outcome measure to assess QOL, was included.</div></div><div><h3>Results</h3><div>Seventy-six responses were received. Overall, 91% (69/76) reported olfactory problems. Mean BQOD score was 5.0 (standard deviation=4.8), indicating olfactory QOL impairment was present. Ninety-five percent (72/76) reported research on OD is worthwhile and were willing to participate in research.</div></div><div><h3>Conclusion</h3><div>Among PwCF, OD and olfactory-specific QOL impairments are prevalent. There is strong interest and willingness to participate in OD research among the CF community.</div></div>","PeriodicalId":15452,"journal":{"name":"Journal of Cystic Fibrosis","volume":"23 6","pages":"Pages 1195-1198"},"PeriodicalIF":5.4000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cystic Fibrosis","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1569199323016776","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Olfactory dysfunction (OD) is prevalent in people with cystic fibrosis (PwCF) and can negatively impact quality-of-life (QOL). This study evaluated perceptions of OD, investigated how OD impacts QOL, and assessed willingness to participate in OD research among the CF community.

Methods

A 21-question survey was distributed through the CF Foundation's Community Voice program in 2023. The survey included questions on olfaction and interest in research. The Brief Questionnaire of Olfactory Disorders (BQOD), a validated person-reported outcome measure to assess QOL, was included.

Results

Seventy-six responses were received. Overall, 91% (69/76) reported olfactory problems. Mean BQOD score was 5.0 (standard deviation=4.8), indicating olfactory QOL impairment was present. Ninety-five percent (72/76) reported research on OD is worthwhile and were willing to participate in research.

Conclusion

Among PwCF, OD and olfactory-specific QOL impairments are prevalent. There is strong interest and willingness to participate in OD research among the CF community.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
囊性纤维化患者嗅觉丧失:社区认知和影响。
背景:嗅觉功能障碍(OD)在囊性纤维化(PwCF)患者中普遍存在,并可能对生活质量(QOL)产生负面影响。本研究评估了CF群体对OD的感知,调查了OD如何影响生活质量,并评估了参与OD研究的意愿。方法:在2023年通过CF基金会的社区之声项目进行了一项包含21个问题的调查。调查的问题包括嗅觉和研究兴趣。嗅觉障碍简要问卷(BQOD)是一种经过验证的评估生活质量的个人报告结果测量方法。结果:共收到76份回复。总体而言,91%(69/76)报告嗅觉问题。平均BQOD评分为5.0(标准差为4.8),表明存在嗅觉生活质量下降。95%(72/76)的人表示对吸毒过量的研究是值得的,并且愿意参与研究。结论:在PwCF患者中,OD和嗅觉特异性生活质量损害较为普遍。CF社区对参与OD研究有强烈的兴趣和意愿。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Cystic Fibrosis
Journal of Cystic Fibrosis 医学-呼吸系统
CiteScore
10.10
自引率
13.50%
发文量
1361
审稿时长
50 days
期刊介绍: The Journal of Cystic Fibrosis is the official journal of the European Cystic Fibrosis Society. The journal is devoted to promoting the research and treatment of cystic fibrosis. To this end the journal publishes original scientific articles, editorials, case reports, short communications and other information relevant to cystic fibrosis. The journal also publishes news and articles concerning the activities and policies of the ECFS as well as those of other societies related the ECFS.
期刊最新文献
Advertisement for Editor-in-Chief, Journal of Cystic Fibrosis. Real-world association between ivacaftor initiation and lung function variability: A registry study. Mycobacterium abscessus biofilm cleared from murine lung by monoclonal antibody against bacterial DNABII proteins. Personalized therapy with CFTR modulators: Response of p.Ile148Asn variant. Real-world outcomes of generic elexacaftor/tezacaftor/ivacaftor (gETI) in South Africans (SA) with CF using standard versus clarithromycin-boosted gETI, modulator-sparing strategies to reduce cost.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1